StockSelector.com
  Research, Select, & Monitor Monday, April 23, 2018 11:32:27 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Cymabay Therapeutics, Inc.$12.94($.50)(3.72%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Cymabay Therapeutics, Inc. has an overall rank of 3627 out of 6819 stocks based on 7 positive rankings and 6 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $22.50 for Cymabay Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Cymabay Therapeutics is ranked 153.
90 Day Gain
Cymabay Therapeutics rank is 209
10 Day Gain
Cymabay Therapeutics rank is 214
Historic Revenue Growth
Cymabay Therapeutics rank is 459
Debt-to-Equity
Cymabay Therapeutics rank is 478
Low vPut/Call
Cymabay Therapeutics has a low Put/Call ratio of 0.25 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cymabay Therapeutics is ranked 481.
Up EPS Surprise
Cymabay Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
High Put/Call
Cymabay Therapeutics has a high Put/Call ratio of 7.50 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Cymabay Therapeutics is ranked 38.
Price-to-Sales
Cymabay Therapeutics rank is 132
Negative Net Margin
Cymabay Therapeutics rank is 288
Price-to-Book
Cymabay Therapeutics rank is 475
Negative ROE
Cymabay Therapeutics rank is 698
Negative ROA
Cymabay Therapeutics rank is 708







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.